02:13 PM EST, 01/06/2025 (MT Newswires) -- Jonathan Young, Chief Operating Officer, on January 02, 2025, sold 10,000 shares in Akero Therapeutics ( AKRO ) for $280,330. Following the Form 4 filing with the SEC, Young has control over a total of 278,083 shares of the company, with 218,083 shares held directly and 60,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1744659/000095017025001850/xslF345X05/ownership.xml

Price: 28.00, Change: -0.24, Percent Change: -0.85